Enveric Biosciences, Inc. financial data

Symbol
ENVB on Nasdaq
Industry
Pharmaceutical Preparations
Location
4851 Tamiami Trail N, Suite 200, Naples, FL
State of incorporation
DE
Fiscal year end
December 31
Former names
AMERI Holdings, Inc. (to 12/30/2020), SPATIALIZER AUDIO LABORATORIES INC (to 5/27/2015)
Latest financial report
10-Q - Q2 2024 - Aug 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 243 % -39.9%
Debt-to-equity 29.7 % +12.7%
Return On Assets -164 % -40.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8.92M shares +315%
Common Stock, Shares, Outstanding 7.88M shares +268%
Entity Public Float 7.1M USD -35.5%
Common Stock, Value, Issued 78.8K USD +268%
Weighted Average Number of Shares Outstanding, Basic 7.59M shares +260%
Weighted Average Number of Shares Outstanding, Diluted 7.59M shares +260%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 4M USD -51%
General and Administrative Expense 5.86M USD -53.3%
Operating Income (Loss) -10.2M USD +64.2%
Nonoperating Income (Expense) -356K USD -107%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -10.6M USD +70.4%
Income Tax Expense (Benefit) 1.73K USD
Net Income (Loss) Attributable to Parent -10.6M USD +52.3%
Earnings Per Share, Basic -3.6 USD/shares +65%
Earnings Per Share, Diluted -3.6 USD/shares +91.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 5.52M USD -38%
Property, Plant and Equipment, Net 405K USD -31.9%
Operating Lease, Right-of-Use Asset 9.61K USD -92.1%
Intangible Assets, Net (Excluding Goodwill) 169K USD
Goodwill 253K USD -82.8%
Assets 6.05M USD -38.3%
Accounts Payable, Current 460K USD -62.7%
Accrued Liabilities, Current 176K USD -88.2%
Liabilities, Current 645K USD -86.9%
Operating Lease, Liability, Noncurrent 9.87K USD
Other Liabilities, Noncurrent 2.51M USD
Liabilities 4M USD -9.45%
Accumulated Other Comprehensive Income (Loss), Net of Tax -566K USD -3.74%
Retained Earnings (Accumulated Deficit) -101M USD -11.7%
Stockholders' Equity Attributable to Parent 5.41M USD +10.9%
Liabilities and Equity 6.05M USD -38.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.6M USD +49.4%
Net Cash Provided by (Used in) Financing Activities 6.66M USD
Net Cash Provided by (Used in) Investing Activities -5.17K USD +99%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 7.88M shares +268%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 4.07M USD
Interest Paid, Excluding Capitalized Interest, Operating Activities 4.14K USD
Deferred Tax Assets, Valuation Allowance 12.8M USD +16.9%
Operating Lease, Liability 63.8K USD -63.8%
Depreciation 172K USD -2.81%
Payments to Acquire Property, Plant, and Equipment 5.17K USD -99%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -10.6M USD +53.7%
Lessee, Operating Lease, Liability, to be Paid 64.2K USD -66.6%
Operating Lease, Liability, Current 9.61K USD -91.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 64.2K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 415 USD -97.4%
Deferred Tax Assets, Operating Loss Carryforwards 10.9M USD +22%
Preferred Stock, Shares Authorized 20M shares 0%
Additional Paid in Capital 107M USD +11.6%
Amortization of Intangible Assets 169K USD +0%
Share-based Payment Arrangement, Expense 1.41M USD -40.8%
Interest Expense 5.25K USD
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%